Icariin ameliorates LPS-induced acute lung injury in mice via complement C5a-C5aR1 and TLR4 signaling pathways

Copyright © 2024 Elsevier B.V. All rights reserved..

Acute lung injury (ALI) is an acute respiratory-related progressive disorder, which lacks specific pharmacotherapy. Icariin (ICA) has been shown to be effective in treating ALI. However, the targets and pharmacological mechanisms underlying the effects of ICA in the treatment of ALI are relatively lacking. Based on network pharmacology and molecular docking analyses, the gene functions and potential target pathways of ICA in the treatment of ALI were determined. In addition, the underlying mechanisms of ICA were verified by immunohistochemistry, immunofluorescence, quantitative Real-time PCR, and Western blot in LPS-induced ALI mice. The biological processes targeted by ICA in the treatment of ALI included the pathological changes, inflammatory response, and cell signal transduction. Network pharmacology, molecular docking, and in vivo experimental results revealed that ICA inhibited the complement C5a-C5aR1 axis, TLR4 mediated NF-κB, MAPK, and JAK2-STAT3 signaling pathways related gene and protein expressions, and decreased inflammatory cytokine, chemokine, adhesion molecule expressions, and mitochondrial apoptosis in LPS-induced ALI.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:131

Enthalten in:

International immunopharmacology - 131(2024) vom: 20. Apr., Seite 111802

Sprache:

Englisch

Beteiligte Personen:

Guo, Jing [VerfasserIn]
Zhang, Qi-Yun [VerfasserIn]
Xu, Lin [VerfasserIn]
Li, Min [VerfasserIn]
Sun, Qian-Yun [VerfasserIn]

Links:

Volltext

Themen:

80295-54-1
Acute lung injury
Complement
Complement C5a
Flavonoids
Icariin
Inflammation
Journal Article
Lipopolysaccharides
Mitochondrial apoptosis
NF-kappa B
Receptors, Complement
Toll-Like Receptor 4
VNM47R2QSQ

Anmerkungen:

Date Completed 10.04.2024

Date Revised 12.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.intimp.2024.111802

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369568109